Fig. 2From: Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farmPCV2 serological results, by vaccination group and week of age legend: Statistical differences levels: Week 3: p = 0.9162, Week 6 p = 0.3069, Week 10 p < 0.0001, Week 14 p < 0.0001, Week 18 p = 0.0013, Week 22 p < 0.0001Back to article page